Drug-labels.com

Telebrix 38 Oral: Uses, Side Effects and Dosage

Status:
Current status: Cancelled Post Market Facts
Strength:
513 mg / 255 mg
Active ingredients:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Patient Medication Information: uses, side effects, how to take - Telebrix 38 Oral

What is Telebrix 38 Oral used for?

Telebrix 38 Oral:

  • is for diagnostic use only and is used to help identify an illness.
  • makes contrast in the abdomen that is useful during a CT scan of the abdomen and pelvis.
  • is used in children and adults.

How does Telebrix 38 Oral work?

Telebrix 38 Oral creates contrast in the abdomen. This makes it easier for your doctor to interpret the results of your CT scan and make a diagnosis

What are the ingredients in Telebrix 38 Oral?

Medicinal ingredients: Ioxitalamic Acid.

Non-medicinal ingredients: Disodium Calcium Edetate USP, Meglumine USP, Monobasic Sodium Phosphate USP and Sodium Hydroxide EP.

Telebrix 38 Oral comes in the following dosage forms:

30 and 120 mL bottle

Do not use Telebrix 38 Oral if:

  • You are hypersensitive to this drug or to any ingredient in the formulation or component of the container.
  • You have severe issues with the production of urine (oliguria or anuria).
  • You have a history of immediate or delayed major skin reaction to Telebrix.
  • You have an abnormal broncho-esophageal connection.
  • You manifest thyrotoxicosis (which means having too much thyroid hormone in your body).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Telebrix 38 Oral. Talk about any health conditions or problems you may have, including if you:

  • have had a previous allergic reaction to a contrast agent.
  • had to take another contrast agent like Telebrix 38 Oral in the last few days.
  • have a history of bronchial asthma and if you had an asthma attack within the last 8 days.
  • have kidney problems or a history of kidney problems.
  • have diabetes

  • have severe heart problems, including:

    • a recent heart attack
    • an intra-aortic balloon pump
    • heart failure
    • artery disease
    • damage to or defect in one of the four heart valves (valvular heart disease)
    • a type of blood pressure that affects your lungs and the right side of your heart (pulmonary arterial hypertension)
  • have multiple myeloma (cancer of the plasma blood cells)
  • have both liver failure and kidney failure.
  • have an enlarged thyroid gland (goiter) or problems with your thyroid gland (dysthyroidism).
  • had a transient ischemic attack (similar to a stroke), a stroke, bleeding or swelling in your brain or epilepsy.
  • have a rare tumour on your adrenal gland (pheochromocytoma).
  • have myasthenia gravis.

  • are pregnant or could be pregnant. If you may need to take Telebrix 38 Oral during your pregnancy, your doctor will discuss the benefits and risks of giving it to you.

  • are breast-feeding. It is not known if Telebrix 38 Oral is excreted in breast milk. You should bottle feed your baby for at least 24 hours after taking Telebrix 38 Oral.

Other warnings you should know about:

Thyroid function

Contrast media containing iodine, such as Telebrix, may change thyroid activity in some patients, both in adults and infants. This may cause:

  • Hypothyroidism (i.e. too little thyroid hormones in the blood)
  • Or hyperthyroidism (i.e. too much thyroid hormones in the blood)

Thyroid function in infants

Contrast media containing iodine may cause hypothyroidism in infants, especially infants born too soon that:

  • Can continue for several weeks to a month after treatment
  • Can harm growth and development
  • Can harm mental growth
  • May require treatment

  • Can cause symptoms such as:

    • Fatigue, shortness of breath, low heart rate
    • Reduced appetite, feeling cold, weight gain
    • Muscle stiffness

Contact your doctor if these symptoms happen to you or your infant.

Your doctor may order blood tests for your infant after treatment to follow thyroid hormone levels in the blood.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Telebrix® 38 Oral

  • Radiopharmaceuticals (used for diagnosis of medical conditions).
  • Beta-blockers (used to lower blood pressure)
  • Vasoactive substances (drugs used to increase or decrease blood pressure)
  • Angiotensin receptor antagonists (used to treat high blood pressure and heart failure).
  • Diuretics (used to help your body excrete more fluids as urine).
  • Interleukin-2 (used to treat cancer).
  • Drugs that may be toxic to the kidneys
  • Fibrinolytic Agents (used to dissolve blood clots).

How to take Telebrix 38 Oral ?

Telebrix 38 Oral will always be used in a hospital or similar setting. It will only be administered to you under the supervision of a health professional skilled and experienced in the particular procedure to be performed.

Usual dose:

Your doctor will determine the amount of Telebrix 38 Oral to be used. The dose administered will depend on your weight, your age and the procedure. You will have to take Telebrix 38 Oral twice:

  • several hours before your CT scan and
  • at least 30 minutes before your CT scan

Overdose:

If you think you have been given too much Telebrix 38 Oral, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

What are possible side effects from using Telebrix 38 Oral?

These are not all the possible side effects you may feel when taking Telebrix 38 Oral. If you experience any side effects not listed here, contact your healthcare professional.

Common side effects may include:

  • Hypersensitivity, allergic reaction, rash, injection site reactions.

Other side effects may include:

  • Somnolence, dizziness.
  • Swollen eyelids.
  • Swelling, severe itching, erythema, excessive sweating, edema, pain, chills.

Serious side effects and what to do about them

Symptom/ EffectTalk to your healthcare professional
Only if severeIn all cases

UNCOMMON

  • Lack of a sufficient amount of the thyroid hormone (known as hypothyroidism)
  • Over- or under-function of the thyroid hormone.
  • Temporary loss of consciousness.
  • Cardiac arrest, rapid heartbeat, bluish discoloration of the skin (cyanosis).
  • High or low blood pressure.
  • Swelling in the throat, swelling in the lungs, difficult or labor breathing, cough, sneezing.
  • Painful obstruction of a part of the intestine (ileus), inflammation of the small intestine and the colon, diarrhea, nausea, vomiting, abdominal pain.
  • Symptom that shows that your kidneys are not working well known as serum creatinine increased.
✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store at 15oC to 30°C. Protect from light and freezing. Keep out of reach and sight of children.

If you want more information about Telebrix 38 Oral:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website or by calling 1-844-208-7620.

Liebel-Flarsheim Canada Inc.

Pointe-Claire, Quebec, H9R 5H8

CANADA

Telebrix is a trademark of Guerbet.

Revision: 08/2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02131684

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Telebrix 38 Oral

DIN 02131684
Schedule(s) ETHICAL
Active ingredient(s) Meglumine ioxitalamate 513 MG, Sodium ioxitalamate 255 MG
Dosage form(s) Solution
Route(s) of administration Oral
Drug class (WHO ATC)
  1. V Various drug classes
    1. V08 Contrast media
      1. V08A X-ray contrast media, iodinated
        1. V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
          1. V08AA05 Ioxitalamic acid
Company LIEBEL-FLARSHEIM CANADA INC
Current status Cancelled Post Market
Current status date August 7, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.